Medical imaging is a brilliant field filled with brilliant minds, writes Matthew Leming, PhD candidate in Psychiatry for The Conversation. So why don’t we see more new technologies making it into hospitals?
The next generation of imaging technology, newly installed at the University of Cambridge, will give researchers an unprecedented view of the human body – in particular of the myriad connections within our brains and of tumours as they grow and respond to treatment – and could pave the way for development of treatments personalised for individual patients.
Adolescence is a dangerous time for the onset of mental health problems. Advances in brain imaging are helping to picture how neural changes in these crucial years can lead to chronic debilitating mental illness.
People diagnosed with schizophrenia who are prone to hallucinations are likely to have structural differences in a key region of the brain compared to both healthy individuals and people diagnosed with schizophrenia who do not hallucinate, according to research published today.
Young adults diagnosed with attention deficit/hyperactivity disorder (ADHD) in adolescence show differences in brain structure and perform poorly in memory tests compared to their peers, according to new research from the University of Cambridge, UK, and the University of Oulu, Finland.
A partnership led by the Medical Research Council (MRC) has awarded the University of Cambridge £25 million to provide cutting-edge equipment and infrastructure for its clinical research, from imaging single disease cells through to improved targeting of treatments for patients.
A team of chemists from the University of Cambridge and New York University has developed a method for examining the inner workings of battery-like devices called supercapacitors, which can be charged up extremely quickly and can deliver high electrical power. Their technique, based on magnetic resonance imaging (MRI), establishes a means for monitoring and potentially enhancing the performance of such devices.